| scholarly article | Q13442814 |
| P50 | author | Oliver John Semmes | Q55274745 |
| Juan Yakisich | Q72596771 | ||
| Sucharita Dutta | Q121289475 | ||
| Vivek Kaushik | Q121289476 | ||
| Vani Ramesh | Q121289479 | ||
| P2093 | author name string | Yogesh M Kulkarni | |
| Anand Krishnan V Iyer | |||
| Neelam Azad | |||
| Rajkumar Venkatadri | |||
| Clayton A Wright | |||
| P2860 | cites work | Autophagy in idiopathic pulmonary fibrosis | Q21134133 |
| Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses | Q23918832 | ||
| Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production | Q23924071 | ||
| Identification of aberrant pathways and network activities from high-throughput data | Q26829854 | ||
| Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
| Fibrosis and angiogenesis | Q28142662 | ||
| PI3K/PTEN signaling in angiogenesis and tumorigenesis | Q28383083 | ||
| Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF | Q28389679 | ||
| Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload | Q28507674 | ||
| Creating and analyzing pathway and protein interaction compendia for modelling signal transduction networks | Q28727977 | ||
| Wnt signaling: a common theme in animal development | Q29547527 | ||
| Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion. | Q30512379 | ||
| Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration | Q33357303 | ||
| Retracted: Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo | Q33572999 | ||
| Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling | Q33605369 | ||
| The thrombospondin 1-TGF-beta axis in fibrotic renal disease | Q33966594 | ||
| Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings | Q34019921 | ||
| Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans | Q34245363 | ||
| Deregulated Akt3 activity promotes development of malignant melanoma | Q34355872 | ||
| Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis | Q34371260 | ||
| Activation of oncogenic pathways in idiopathic pulmonary fibrosis | Q34478556 | ||
| Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice | Q34816420 | ||
| Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. | Q35534165 | ||
| Integrin-linked kinase mediates CTGF-induced epithelial to mesenchymal transition in alveolar type II epithelial cells. | Q52976377 | ||
| Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. | Q53578148 | ||
| Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism. | Q54293135 | ||
| Idiopathic Pulmonary Fibrosis | Q56804123 | ||
| Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation | Q59280520 | ||
| Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats | Q71579442 | ||
| Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology | Q83069601 | ||
| Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis | Q83662374 | ||
| Angiogenic cytokines in patients with idiopathic interstitial pneumonia | Q35536768 | ||
| microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. | Q35740215 | ||
| Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis | Q35863725 | ||
| MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation | Q35889180 | ||
| PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis | Q35994534 | ||
| Integrin-linked kinase: a cancer therapeutic target unique among its ILK. | Q35998768 | ||
| Proteomics approaches to fibrotic disorders | Q36012560 | ||
| Molecular and cellular mechanisms of pulmonary fibrosis | Q36237168 | ||
| Simple method of estimating severity of pulmonary fibrosis on a numerical scale | Q36451354 | ||
| Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? | Q36493959 | ||
| GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism | Q36890830 | ||
| Molecular targets in pulmonary fibrosis: the myofibroblast in focus. | Q36969931 | ||
| The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 | ||
| Wnt pathway in pulmonary fibrosis in the bleomycin mouse model | Q36991705 | ||
| Protein networks in disease | Q37125547 | ||
| Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis | Q37330584 | ||
| Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast | Q37438108 | ||
| Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway | Q37479693 | ||
| The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma | Q37506648 | ||
| Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury | Q37591248 | ||
| Angiogenesis in pulmonary fibrosis: too much or not enough? | Q38026412 | ||
| A novel role of vimentin filaments: binding and stabilization of collagen mRNAs | Q38285932 | ||
| A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls. | Q38473170 | ||
| Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis | Q39611228 | ||
| Integrin-linked kinase (ILK) in pulmonary fibrosis | Q39835492 | ||
| Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice | Q39856751 | ||
| Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice | Q40117789 | ||
| MEK/ERK inhibitors: proof-of-concept studies in lung fibrosis | Q40816517 | ||
| HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis | Q42032624 | ||
| Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis | Q42721872 | ||
| Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis. | Q43563544 | ||
| Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2. | Q43619011 | ||
| Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity | Q43729054 | ||
| Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors | Q43815149 | ||
| Natural killer cell signaling pathways | Q45165250 | ||
| Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis | Q45215820 | ||
| A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. | Q51092771 | ||
| STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. | Q52575315 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 33-46 | |
| P577 | publication date | 2015-11-24 | |
| P1433 | published in | Proteomics | Q15614164 |
| P1476 | title | A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis | |
| P478 | volume | 16 |
| Q47761263 | A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis. |
| Q36148263 | Comparative proteome profiling of bleomycin-induced lung toxicity in rats by 2D-nano-LC-MS/MS and spectral counting |
| Q47448022 | Early Detection of Urinary Proteome Biomarkers for Effective Early Treatment of Pulmonary Fibrosis in a Rat Model |
| Q99634847 | Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review |
| Q90447332 | Lysyl hydroxylase 3 increases collagen deposition and promotes pulmonary fibrosis by activating TGFβ1/Smad3 and Wnt/β-catenin pathways |
| Q38744738 | MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and Wnt Signaling |
| Q46491430 | Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model. |
| Q64083648 | Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer |
| Q47198646 | Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes. |
Search more.